Sirona Biochem Corp. (SRBCF)
- Previous Close
0.0000 - Open
0.0211 - Bid 0.0176 x --
- Ask 0.0214 x --
- Day's Range
0.0186 - 0.0211 - 52 Week Range
0.0013 - 0.0680 - Volume
15,000 - Avg. Volume
32,777 - Market Cap (intraday)
11.128M - Beta (5Y Monthly) -0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 26, 2025 - Jun 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
www.sironabiochem.comRecent News: SRBCF
View MorePerformance Overview: SRBCF
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SRBCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SRBCF
View MoreValuation Measures
Market Cap
11.13M
Enterprise Value
13.48M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-148.11%
Return on Equity (ttm)
--
Revenue (ttm)
-16.36k
Net Income Avi to Common (ttm)
-2.67M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
33.62k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.26M